Comparison Overview

Zuellig Pharma

VS

Greater Paris University Hospitals - AP-HP

Zuellig Pharma

47 Scotts Road Goldbell Towers, #10-00 Singapore, Singapore 228233, SG
Last Update: 2025-11-21
Between 750 and 799

Zuellig Pharma is a leading integrated healthcare solutions company in Asia with experience spanning over a century in the region. Partnering with multinational pharmaceutical manufacturers, governments, healthcare providers, and professionals, we broaden access to pharmaceutical and healthcare products. This is achieved through our services across three Business Units: Distribution, Commercialization, and Clinical Trial Support. Our purpose of ‘Making Healthcare More Accessible’ is driven by our three values: upholding the highest standards of integrity and excellence, embracing a growth mindset, and collaborating for shared success.

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 10,001
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Greater Paris University Hospitals - AP-HP

55, Boulevard Diderot, Paris, Île-de-France, FR, 75012
Last Update: 2025-11-20
Between 750 and 799

AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there.

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 20,296
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/zuellig-pharma.jpeg
Zuellig Pharma
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/ap-hp.jpeg
Greater Paris University Hospitals - AP-HP
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Zuellig Pharma
100%
Compliance Rate
0/4 Standards Verified
Greater Paris University Hospitals - AP-HP
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Zuellig Pharma in 2025.

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Greater Paris University Hospitals - AP-HP in 2025.

Incident History — Zuellig Pharma (X = Date, Y = Severity)

Zuellig Pharma cyber incidents detection timeline including parent company and subsidiaries

Incident History — Greater Paris University Hospitals - AP-HP (X = Date, Y = Severity)

Greater Paris University Hospitals - AP-HP cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/zuellig-pharma.jpeg
Zuellig Pharma
Incidents

No Incident

https://images.rankiteo.com/companyimages/ap-hp.jpeg
Greater Paris University Hospitals - AP-HP
Incidents

No Incident

FAQ

Greater Paris University Hospitals - AP-HP company demonstrates a stronger AI Cybersecurity Score compared to Zuellig Pharma company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Greater Paris University Hospitals - AP-HP company has disclosed a higher number of cyber incidents compared to Zuellig Pharma company.

In the current year, Greater Paris University Hospitals - AP-HP company and Zuellig Pharma company have not reported any cyber incidents.

Neither Greater Paris University Hospitals - AP-HP company nor Zuellig Pharma company has reported experiencing a ransomware attack publicly.

Neither Greater Paris University Hospitals - AP-HP company nor Zuellig Pharma company has reported experiencing a data breach publicly.

Neither Greater Paris University Hospitals - AP-HP company nor Zuellig Pharma company has reported experiencing targeted cyberattacks publicly.

Neither Zuellig Pharma company nor Greater Paris University Hospitals - AP-HP company has reported experiencing or disclosing vulnerabilities publicly.

Neither Zuellig Pharma nor Greater Paris University Hospitals - AP-HP holds any compliance certifications.

Neither company holds any compliance certifications.

Zuellig Pharma company has more subsidiaries worldwide compared to Greater Paris University Hospitals - AP-HP company.

Greater Paris University Hospitals - AP-HP company employs more people globally than Zuellig Pharma company, reflecting its scale as a Hospitals and Health Care.

Neither Zuellig Pharma nor Greater Paris University Hospitals - AP-HP holds SOC 2 Type 1 certification.

Neither Zuellig Pharma nor Greater Paris University Hospitals - AP-HP holds SOC 2 Type 2 certification.

Neither Zuellig Pharma nor Greater Paris University Hospitals - AP-HP holds ISO 27001 certification.

Neither Zuellig Pharma nor Greater Paris University Hospitals - AP-HP holds PCI DSS certification.

Neither Zuellig Pharma nor Greater Paris University Hospitals - AP-HP holds HIPAA certification.

Neither Zuellig Pharma nor Greater Paris University Hospitals - AP-HP holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.

Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.

Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H